Affordable Access

The long-term clinical impact of biochemical recurrence of prostate cancer 5 or more years after radical prostatectomy.

Authors
  • Ward, John F
  • Blute, Michael L
  • Slezak, Jeffrey
  • Bergstralh, Erik J
  • Zincke, Horst
Type
Published Article
Journal
The Journal of Urology
Publisher
Elsevier
Publication Date
Nov 01, 2003
Volume
170
Issue
5
Pages
1872–1876
Identifiers
PMID: 14532796
Source
Medline
License
Unknown

Abstract

Patients are at prolonged risk for BF and CF following RP. Regardless of the timing of the initial PSA recurrence the PSA doubling time is the most powerful predictor of progression, stratifying patients with BF into high and low risk groups for CF.

Report this publication

Statistics

Seen <100 times